We use innovative biotechnologies to develop fast, simple and accessible molecular testing solutions.
Limay Biosciences has raised $600K in total funding. The most recent round was Seed. The last funding was announced in August 2022.
Limay Biosciences's investors include SF500, Cites.
Limay Biosciences is headquartered in Buenos Aires, Argentina.
We use innovative biotechnologies to develop fast, simple and accessible molecular testing solutions.
Limay Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Limay Biosciences — Funding & Investors." VCBacked, August 12, 2022, https://www.vcbacked.co/company/limay-biosciences. Accessed November 11, 2026.
VCBacked. (2022). Limay Biosciences — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/limay-biosciences
{{cite web |title=Limay Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/limay-biosciences |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Limay Biosciences? Request a listing update